Characterization of HD-V2 Gafchromic Film for Measurement of Spatial Dose Distribution from Alpha Particle of 5.5 MeV

Authors: A. Aydarous, M. El Ghazaly

Abstract:

The purpose of this study was to investigate the response of the newly released Gafchromic HD-V2 film for alpha particle of 5.5 MeV. Gafchromic HD-V2 was exposed to alpha particles of energy 5 MeV from 241Am for different durations. Then the films were scanned with a flatbed scanner. The dose response curve up to 2200 Gy has been achieved. The film’s reproducibility and sensitivity were evaluated. The results obtained show that the net optical density increases almost exponentially with the increase in the exposure time, and it becomes saturated after prolonged exposure times. The red channel shows the highest sensitivity, with a value of 4 x 10-3 Gy-1 at netOD of 0.4. The inter-film reproducibility was measured and the relative uncertainty found was 1.7 %, 2.1 % and 2.3 % for grey, red and green channels, respectively.

Keywords: Alpha dosimetry, 241Am, Gafchromic film.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1087324

References:

[1] D. Nikezic, A. K. M. M. Haque, and K. N. Yu, "Absorbed dose delivered by alpha particles calculated in cylindrical geometry," Journal of Environmental Radioactivity, vol. 60, pp. 293–305, 2002.
[2] S. A. Park, et al., "Dose verification of proton beam therapy using the Gafchromic EBT film," Radiation Measurements, vol. 46, pp. 717-721, 2011.
[3] M. R. Zalutsky, et al., "Clinical Experience with a-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6," THE JOURNAL OF NUCLEAR MEDICINE, vol. 49, pp. 30-38, 2007.
[4] B. J. Allen, Z. Tian, S. M. A. Rizvi, Y. Li, and M. Ranson, "Preclinical studies of targeted α therapy for breast cancer using 213Bi-labelledplasminogen activator inhibitor type 2," British Journal of Cancer, vol. 88, pp. 944–950, 2003.
[5] J. C. Roeske, B. Aydogan, M. Bardies, and J. L. Humm, "Small-Scale Dosimetry: Challenges and Future Directions," Semin Nucl Med, vol. 38, pp. 367-383, 2008.
[6] M. W. Charles, "Skin dose from Ra-226 contamination: Dose estimation & comments," unpublished.
[7] Ashland dosimetry systems, "GAFCHROMIC dosimetry media, type HD-V2," ed, 2012.
[8] A. S. Aydarous, M. W. Charles, and P. J. Darley, "Dose distribution measurements and calculations for Dounreay hot particles," Radiation Protection Dosimetry, vol. 128, pp. 146-158, 2008.
[9] M. J. Schepis, et al., "Measurement of the sensitivity and spatial resolution of radiochromic film using ion beams and X-rays," Submitted for the DPP12 Meeting of The American Physical Society, 2013.
[10] A. Niroomand-Rad, et al., "Radiochromic film dosimetry: recommendations of AAPM Radiation Therapy Committee Task Group 55," Med. Phys., vol. 25, 1998.
[11] A. S. Aydarous, P. J. Darley, and M. W. Charles, "A wide dynamic range, high-spatial-resolution scanning system for radiochromic dye films," Phys. Med. Biol., vol. 46, pp. 1379–1389, 2001.
[12] Slobodan Devic, et al., "Dosimetric properties of improved GafChromic films for seven different digitizers," Med. Phys., vol. 31, pp. 2392-2401, 2004.
[13] J. Sorriaux, et al., "Evaluation of Gafchromic EBT3 films characteristics in therapy photon, electron and proton beams," Physica Medica, vol. In press, 2012.
[14] L. Wack, et al., "High throughput film dosimetry in homogeneous and heterogeneous media for a small animal irradiator," Physica Medica, vol. In press, 2013.
[15] M. J. Butsona, P. K. N. Yua, T. Cheunga, and P. Metcalfe, "Radiochromic film for medical radiation dosimetry," Materials Science and Engineering, vol. R 41, pp. 61-120, 2003.